Literature DB >> 24733472

Uptake of polymyxin B into renal cells.

Kamilia Abdelraouf1, Kai-Tai Chang2, Taijun Yin1, Ming Hu1, Vincent H Tam3.   

Abstract

Polymyxin B is increasingly used as a treatment of last resort against multidrug-resistant Gram-negative infections. Using a mammalian kidney cell line, we demonstrated that polymyxin B uptake into proximal tubular epithelial cells was saturable and occurred primarily through the apical membrane, suggesting the involvement of transporters in the renal uptake of polymyxin B. Megalin might play a role in the uptake and accumulation of polymyxin B into renal cells.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24733472      PMCID: PMC4068554          DOI: 10.1128/AAC.02557-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Biochemical characterization of renal epithelial cell cultures (LLC-PK1 and MDCK).

Authors:  G Gstraunthaler; W Pfaller; P Kotanko
Journal:  Am J Physiol       Date:  1985-04

2.  Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center.

Authors:  Darowan S Akajagbor; Sharon L Wilson; Kapana D Shere-Wolfe; Paul Dakum; Manhattan E Charurat; Bruce L Gilliam
Journal:  Clin Infect Dis       Date:  2013-07-09       Impact factor: 9.079

3.  Megalin deficiency offers protection from renal aminoglycoside accumulation.

Authors:  Christian Schmitz; Jan Hilpert; Christian Jacobsen; Christian Boensch; Erik Ilsø Christensen; Friedrich C Luft; Thomas E Willnow
Journal:  J Biol Chem       Date:  2001-11-07       Impact factor: 5.157

4.  Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs.

Authors:  S K Moestrup; S Cui; H Vorum; C Bregengård; S E Bjørn; K Norris; J Gliemann; E I Christensen
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

5.  Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections.

Authors:  Magdalena E Sobieszczyk; E Yoko Furuya; Christine M Hay; Preeti Pancholi; Phyllis Della-Latta; Scott M Hammer; Christine J Kubin
Journal:  J Antimicrob Chemother       Date:  2004-07-21       Impact factor: 5.790

6.  Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria.

Authors:  John P Ouderkirk; Jill A Nord; Glenn S Turett; Jay Ward Kislak
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

7.  Ultrastructural localization by monoclonal antibodies of brush border antigens expressed by glomeruli. I. Renal distribution.

Authors:  F Chatelet; E Brianti; P Ronco; J Roland; P Verroust
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

8.  The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border.

Authors:  D Kerjaschki; M G Farquhar
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

9.  Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.

Authors:  Guilherme Henrique Campos Furtado; Pedro Alves d'Azevedo; Anderson Fernandes Santos; Ana Cristina Gales; Antônio Carlos Campos Pignatari; Eduardo Alexandrino Servolo Medeiros
Journal:  Int J Antimicrob Agents       Date:  2007-07-13       Impact factor: 5.283

Review 10.  Use of cultured epithelia to study transport and its regulation.

Authors:  J S Handler
Journal:  J Exp Biol       Date:  1983-09       Impact factor: 3.312

View more
  19 in total

1.  Cellular Uptake and Localization of Polymyxins in Renal Tubular Cells Using Rationally Designed Fluorescent Probes.

Authors:  Bo Yun; Mohammad A K Azad; Cameron J Nowell; Roger L Nation; Philip E Thompson; Kade D Roberts; Tony Velkov; Jian Li
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

2.  Human oligopeptide transporter 2 (PEPT2) mediates cellular uptake of polymyxins.

Authors:  Xiaoxi Lu; Ting Chan; Chenghao Xu; Ling Zhu; Qi Tony Zhou; Kade D Roberts; Hak-Kim Chan; Jian Li; Fanfan Zhou
Journal:  J Antimicrob Chemother       Date:  2015-10-22       Impact factor: 5.790

3.  Clinical outcomes associated with polymyxin B dose in patients with bloodstream infections due to carbapenem-resistant Gram-negative rods.

Authors:  Brian C Nelson; Daniel P Eiras; Angela Gomez-Simmonds; Angela S Loo; Michael J Satlin; Stephen G Jenkins; Susan Whittier; David P Calfee; E Yoko Furuya; Christine J Kubin
Journal:  Antimicrob Agents Chemother       Date:  2015-08-31       Impact factor: 5.191

4.  Human kidney on a chip assessment of polymyxin antibiotic nephrotoxicity.

Authors:  Elijah J Weber; Kevin A Lidberg; Lu Wang; Theo K Bammler; James W MacDonald; Mavis J Li; Michelle Redhair; William M Atkins; Cecilia Tran; Kelly M Hines; Josi Herron; Libin Xu; Maria Beatriz Monteiro; Susanne Ramm; Vishal Vaidya; Martti Vaara; Timo Vaara; Jonathan Himmelfarb; Edward J Kelly
Journal:  JCI Insight       Date:  2018-12-20

5.  Nephrotoxicity Associated with Intravenous Polymyxin B Once- versus Twice-Daily Dosing Regimen.

Authors:  Adeola Okoduwa; Nabeela Ahmed; Yi Guo; Marco R Scipione; John Papadopoulos; Daniel P Eiras; Yanina Dubrovskaya
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

6.  Reply to "measuring polymyxin uptake by renal tubular cells: is BODIPY-polymyxin B an appropriate probe?".

Authors:  Kamilia Abdelraouf; Vincent H Tam
Journal:  Antimicrob Agents Chemother       Date:  2014-10       Impact factor: 5.191

7.  Measuring polymyxin uptake by renal tubular cells: is BODIPY-polymyxin B an appropriate probe?

Authors:  Mohammad A K Azad; Bo Yun; Kade D Roberts; Roger L Nation; Philip E Thompson; Tony Velkov; Jian Li
Journal:  Antimicrob Agents Chemother       Date:  2014-10       Impact factor: 5.191

Review 8.  Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?

Authors:  Alexandre P Zavascki; Roger L Nation
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

9.  Preliminary clinical study of the effect of ascorbic acid on colistin-associated nephrotoxicity.

Authors:  Rujipas Sirijatuphat; Samornrod Limmahakhun; Vorapan Sirivatanauksorn; Roger L Nation; Jian Li; Visanu Thamlikitkul
Journal:  Antimicrob Agents Chemother       Date:  2015-03-23       Impact factor: 5.191

10.  In vitro mechanistic studies on α-amanitin and its putative antidotes.

Authors:  Daniela Ferreira Rodrigues; Ricardo Pires das Neves; Alexandra T P Carvalho; Maria Lourdes Bastos; Vera M Costa; Félix Carvalho
Journal:  Arch Toxicol       Date:  2020-03-19       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.